KLRA Kailera Therapeutics, Inc.

NASDAQ
$16.23

Kailera Therapeutics, Inc. (KLRA) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

Not enough price history for KLRA to build a seasonal study.